Re: Immediate versus Deferred Chemotherapy after Radical Cystectomy in Patients with pT3-pT4 or N+M0 Urothelial Carcinoma of the Bladder (EORTC 30994): An Intergroup, Open-Label, Randomised Phase 3 Trial Editorial Comment

Chang Sam S.

首页> 外文期刊>The Journal of Urology >Re: Immediate versus Deferred Chemotherapy after Radical Cystectomy in Patients with pT3-pT4 or N+M0 Urothelial Carcinoma of the Bladder (EORTC 30994): An Intergroup, Open-Label, Randomised Phase 3 Trial Editorial Comment

【24h】

Re: Immediate versus Deferred Chemotherapy after Radical Cystectomy in Patients with pT3-pT4 or N+M0 Urothelial Carcinoma of the Bladder (EORTC 30994): An Intergroup, Open-Label, Randomised Phase 3 Trial Editorial Comment

机译：回复：膀胱癌pT3-pT4或N + M0膀胱癌根治性膀胱切除术后即刻化疗与延期化疗（EORTC 30994）：一项小组间，开放标签，随机3期试验社论评论

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Journal of Urology》 |2016年第1期|共2页
作者
Chang Sam S.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献

1. Re: Immediate versus Deferred Chemotherapy after Radical Cystectomy in Patients with pT3-pT4 or N+M0 Urothelial Carcinoma of the Bladder (EORTC 30994): An Intergroup, Open-Label, Randomised Phase 3 Trial Editorial Comment [J] . Chang Sam S. The Journal of Urology . 2016,第1期

机译：回复：膀胱癌pT3-pT4或N + M0膀胱癌根治性膀胱切除术后即刻化疗与延期化疗（EORTC 30994）：一项小组间，开放标签，随机3期试验社论评论
2. Comment re: Sternberg CN, Skoneczna I, Kerst JM, et al. Immediate Versus Deferred Chemotherapy After Radical Cystectomy in Patients with pT3-pT4 or N+M0 Urothelial Carcinoma of the Bladder (EORTC 30994): An Intergroup, Open-label, Randomised Phase 3 Trial. Lancet Oncol 2015;16:76-86 [J] . Ohlmann Carsten-Henning, Stoeckle Michael European urology . 2015,第6期

机译：评论RE：Sternberg CN，Skoneczna I，Kerst Jm，等。在膀胱PT3-PT4或N + M0尿路上皮癌的患者中立即与延迟化疗后的膀胱切除术后（EORTC 30994）：杂交，开放标签，随机相3试验。柳叶刀2015年; 16：76-86
3. Re: Immediate Versus Deferred Chemotherapy After Radical Cystectomy in Patients with pT3-pT4 or N+M0 Urothelial Carcinoma of the Bladder (EORTC 30994): An Intergroup, Open-label, Randomised Phase 3 Trial [J] . Sonpavde Guru, Pal Sumanta European urology . 2016,第1期

机译：回复：pT3-pT4或N + M0膀胱尿路上皮癌的根治性膀胱切除术后立即进行延期化疗（EORTC 30994）：组间，开放标签，随机3期试验
4. EORTC-1203-GITCG - the INNOVATION-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab versus chemotherapy plus trastuzumab plus pertuzumab in the perioperative treatment of HER2 positive gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group Korean Cancer Study Group and Dutch Upper GI-Cancer group [O] . Anna Dorothea Wagner, Heike I. Grabsch, Murielle Mauer, 2019

机译：EORTC-1203-GITCG-创新试验：单纯化疗与化疗加曲妥珠单抗相比与化疗加曲妥珠单抗加帕妥珠单抗在围手术期治疗HER2阳性胃和胃食管交界处腺癌对病理反应率的影响：随机阶段EORTC-胃肠道癌组韩国癌症研究组和荷兰上消化道癌组的II组间试验
5. Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial [O] . Sternberg Cora N, Skoneczna Iwona, Kerst J Martijn, 2015

机译：pT3-pT4或N + M0膀胱尿路上皮癌的根治性膀胱切除术后即刻化疗与延迟化疗（EORTC 30994）：一项小组间，开放标签，随机3期试验

Re: Immediate versus Deferred Chemotherapy after Radical Cystectomy in Patients with pT3-pT4 or N+M0 Urothelial Carcinoma of the Bladder (EORTC 30994): An Intergroup, Open-Label, Randomised Phase 3 Trial Editorial Comment

著录项

相似文献

相关主题

期刊订阅